rs140952583

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_000393.5(COL5A2):ā€‹c.4067A>Gā€‹(p.Asp1356Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000491 in 1,613,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00035 ( 0 hom., cov: 32)
Exomes š‘“: 0.00051 ( 0 hom. )

Consequence

COL5A2
NM_000393.5 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8O:1

Conservation

PhyloP100: 3.96
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), COL5A2. . Gene score misZ 2.4395 (greater than the threshold 3.09). Trascript score misZ 3.3523 (greater than threshold 3.09). GenCC has associacion of gene with Ehlers-Danlos syndrome, classic type, 2, Ehlers-Danlos syndrome, classic type.
BP4
Computational evidence support a benign effect (MetaRNN=0.03685987).
BP6
Variant 2-189036662-T-C is Benign according to our data. Variant chr2-189036662-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 213125.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=7, Uncertain_significance=1, not_provided=1}.
BS2
High AC in GnomAd4 at 53 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL5A2NM_000393.5 linkuse as main transcriptc.4067A>G p.Asp1356Gly missense_variant 52/54 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkuse as main transcriptc.3929A>G p.Asp1310Gly missense_variant 55/57 XP_011508875.1
COL5A2XM_047443251.1 linkuse as main transcriptc.3929A>G p.Asp1310Gly missense_variant 57/59 XP_047299207.1
COL5A2XM_047443252.1 linkuse as main transcriptc.3929A>G p.Asp1310Gly missense_variant 56/58 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkuse as main transcriptc.4067A>G p.Asp1356Gly missense_variant 52/541 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000618828.1 linkuse as main transcriptc.2906A>G p.Asp969Gly missense_variant 45/475 ENSP00000482184.1 A0A087WYX9

Frequencies

GnomAD3 genomes
AF:
0.000348
AC:
53
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000358
AC:
90
AN:
251144
Hom.:
0
AF XY:
0.000361
AC XY:
49
AN XY:
135772
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000810
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000493
Gnomad OTH exome
AF:
0.000654
GnomAD4 exome
AF:
0.000506
AC:
739
AN:
1461552
Hom.:
0
Cov.:
31
AF XY:
0.000481
AC XY:
350
AN XY:
727078
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.000738
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000614
Gnomad4 OTH exome
AF:
0.000298
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152296
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000192
Gnomad4 AMR
AF:
0.000458
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000544
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000516
Hom.:
0
Bravo
AF:
0.000416
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000272
AC:
33
EpiCase
AF:
0.00115
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ehlers-Danlos syndrome, classic type, 2 Benign:2Other:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided, no classification providedphenotyping onlyGenomeConnect - Invitae Patient Insights Network-Variant interpreted as Likely benign and reported on 05-03-2019 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 23, 2023- -
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 30, 2023See Variant Classification Assertion Criteria. -
Uncertain significance, criteria provided, single submitterclinical testingInstitute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU DresdenNov 03, 2021- -
Thrombocytopenia;C1458140:Abnormal bleeding Uncertain:1
Uncertain significance, no assertion criteria providedresearchBirmingham Platelet Group; University of BirminghamMay 01, 2020- -
COL5A2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 13, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 27, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJul 17, 2022- -
Ehlers-Danlos syndrome type 7A Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.62
D;T;D
Eigen
Benign
-0.083
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.74
.;T;T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.037
T;T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
1.7
L;.;L
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.7
D;.;.
REVEL
Uncertain
0.40
Sift
Benign
0.10
T;.;.
Sift4G
Benign
0.52
T;T;.
Polyphen
0.0020
B;.;B
Vest4
0.25
MVP
0.79
MPC
0.34
ClinPred
0.048
T
GERP RS
6.0
Varity_R
0.35
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140952583; hg19: chr2-189901388; API